{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:15:18Z","timestamp":1781244918246,"version":"3.54.1"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.5834","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T22:05:41Z","timestamp":1463263541000},"page":"1367-1370","source":"Crossref","is-referenced-by-count":9,"title":["Acute Tubulointerstitial Nephritis Associated with Infliximab in a Patient with Crohn's Disease"],"prefix":"10.2169","volume":"55","author":[{"given":"Mineto","family":"Ota","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Iwai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Japan"},{"name":"Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Kamiya","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Yoshihashi-Nakazato","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Miyasaka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Kohsaka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ramos-Casals M, Brito-Zerón P, Soto MJ, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol 22: 847-861, 2008.","DOI":"10.1016\/j.berh.2008.09.008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Stokes MB, Foster K, Markowitz GS, et al. Development of glomerulonephritis during anti-TNF-α therapy for rheumatoid arthritis. Nephrol Dial Transplant 20: 1400-1406, 2005.","DOI":"10.1093\/ndt\/gfh832"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Costa MF, Said NR, Zimmermann B. Drug-induced lupus due to anti-tumor necrosis factor α agents. Semin Arthritis Rheum 37: 381-387, 2008.","DOI":"10.1016\/j.semarthrit.2007.08.003"},{"key":"4","unstructured":"4. SaintMarcoux B, DeBandt M; CRI (Club Rhumatismes et Inflammation). Vasculitides induced by TNF α antagonists: a study in 39 patients in France. Joint Bone Spine 73: 710-713, 2006."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hirohama D, Hoshino J, Hasegawa E, et al. Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α. Mod Rheumatol 20: 602-605, 2010.","DOI":"10.3109\/s10165-010-0339-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sokumbi O, Wetter DA, Makol A, Warrington KJ. Vasculitis associated with tumor necrosis factor-α inhibitors. Mayo Clin Proc 87: 739-745, 2012.","DOI":"10.1016\/j.mayocp.2012.04.011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Korsten P, Sweiss NJ, Nagorsnik U, et al. Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab. Am J Kidney Dis 56: e17-e21, 2010.","DOI":"10.1053\/j.ajkd.2010.08.019"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sugimoto T, Yasuda M, Sakaguchi M, et al. Acute interstitial nephritis associated with etanercept. Rheumatol Int 28: 1283-1284, 2008.","DOI":"10.1007\/s00296-008-0609-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Waters AM, Zachos M, Herzenberg AM, Harvey E, Rosenblum ND. Tubulointerstitial nephritis as an extraintestinal manifestation of Crohn's disease. Nat Clin Pract Nephrol 4: 693-697, 2008.","DOI":"10.1038\/ncpneph0955"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Saha MK, Tarek H, Sagar V, Abraham P. Role of tumor necrosis factor inhibitor in granulomatous interstitial nephritis secondary to Crohn's disease. Int Urol Nephrol 46: 229-233, 2014.","DOI":"10.1007\/s11255-012-0362-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chapman JR. Chronic calcineurin inhibitor nephrotoxicity: lest we forget. Am J Transplant 11: 693-697, 2011.","DOI":"10.1111\/j.1600-6143.2011.03504.x"},{"key":"12","unstructured":"12. Cush JJ. Unusual toxicities with TNF inhibition: heart failure and drug-induced lupus. Clin Exp Rheumatol 22: S141-S147, 2004."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fasanmade AA, Adedokun OJ, Ford J, et al. Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis. Eur J Clin Pharmacol 65: 1211-1228, 2009.","DOI":"10.1007\/s00228-009-0718-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ordás I, Mould DR, Feagan BG, Sandborn WJ. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms. Clin Pharmacol Ther 91: 635-646, 2012.","DOI":"10.1038\/clpt.2011.328"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mavragani CP, Niewold TB, Moutsopoulos NM, Pillemer SR, Wahl SM, Crow MK. Augmented interferon-α pathway activation in patients with Sjögren's syndrome treated with etanercept. Arthritis Rheum 56: 3995-4004, 2007.","DOI":"10.1002\/art.23062"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Dai C, Wang H, Sung SS, et al. Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure. Clin Immunol 154: 66-71, 2014.","DOI":"10.1016\/j.clim.2014.06.008"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/10\/55_55.5834\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:42:12Z","timestamp":1498311732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/10\/55_55.5834\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.5834","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}